Evidence Review · Evidence Review
Assisted Reproductive Medicine Vol. 01 · No. 04 2026 Spring
front page/knowledge center/test tube baby
Clinical Decision Framework · Clinical Decision Framework

On the night of menstruation,
How to start an HRT cycle? An evidence-based review of menstrual management and assessment of endometrial shedding before starting HRT artificial cycles

A patient plans to initiate a frozen-thawed embryo transfer hormone replacement cycle for endometrial preparation, but has her period the night before and undergoes vaginal ultrasound evaluation the next day—a common situation that often lacks detailed operational details in formal guidelines.
00
Executive Summary

executive summary

This article focuses on a situation that is quite common in assisted reproduction clinics but often lacks detailed operational details in official guidelines: the patient plans to start a hormone replacement cycle (HRT/artificial cycle) for frozen-thaw embryo transfer to prepare the endometrium, but gets menstruation the night before the start; a vaginal ultrasound evaluation is performed the next day; the doctor recommends "promoting expulsion/promoting soothing" measures such as motherwort, ginger and brown sugar water, foot soaks in hot water, and hot compresses on the lower abdomen, and a follow-up ultrasound the next day to determine whether the endometrium is fully shed. Since the patient's basic information and comorbidities are not specified, this article uses "female of childbearing age, undergoing assisted reproductive HRT cycles, and no clear comorbidities" as the default analysis premise; when it comes to individualized medication and examination thresholds, they are all marked as "adjustable/not unified".[1]

Key points that can be directly used by patients and clinical teams: Baseline assessment prioritizes "whether it is true menstruation, whether pregnancy/uterine cavity lesions/infections need to be ruled out, whether there is obvious intrauterine hemorrhage/fluid accumulation or residual echo, and whether there are functional cysts in the ovaries"; if the baseline is in line with expectations, estrogen can usually be started according to the plan; if the baseline indicates insufficient shedding or abnormal uterine cavity, short-term observation and review of ultrasound can be performed, and if necessary, the cycle can be postponed and further examination (such as hysteroscopy). For those with obvious pain, local heat therapy and ginger are mostly used to relieve pain in the evidence of dysmenorrhea; brown sugar water has insufficient evidence, and can be classified more as rehydration and comfort care.[5]

I.

Menstruation is the breakdown and repair triggered by withdrawal of progesterone

The core triggering mechanism of menstruation and endometrium shedding is the withdrawal of progesterone after the regression of the corpus luteum, accompanied by local inflammation, prostaglandins, vasoconstriction and tissue remodeling; most "thermal/dietary/herbal" measures are more likely to affect pain or subjective discomfort and may not significantly change "whether shedding is completed" within 24 hours.[2]

II.

HRT cycle = controllable timeline

It is common to start estrogen on the 1st to 3rd day of menstruation, then start progesterone based on appropriate endometrium thickness and shape, and match the number of days of progesterone exposure according to embryonic age. Domestic consensus emphasizesIt is not appropriate to decide the cancellation cycle based on thickness alone., should take into account the shape, blood flow and uterine cavity conditions.[3]

III.

Motherwort: extrapolating evidence, safety margins first

Modern evidence focuses more on injectables or perinatal/post-abortion situations (eg, reducing postoperative bleeding, promoting uterine involution) rather than on the management of menstrual loss before ART initiation. It should be regarded as an "empirical, safe margin" optional auxiliary, and special caution should be taken for people with suspected pregnancy, excessive bleeding, and those taking anticoagulant medication.[4]

α
Proposed Research Titles · Topic suggestions

Possible research paper topics and reasons for the topic

Management strategies for menstrual sudden onset before the start of frozen-thaw embryo transfer HRT artificial cycle: evidence-based and consensus integration of ultrasound baseline assessment and review path

It directly corresponds to the clinical process of "menstruation the night before - ultrasound the next day - reexamination the next day", and is suitable for writing a "diagnosis and treatment path" review and process algorithm, and can systematically organize the domestic consensus position on "don't cancel the cycle based on thickness alone".[6]

The application boundary of motherwort in reproductive medicine: from the study of uterine contraction and hemostasis to the extrapolation of evidence and risk control of management before the initiation of assisted reproductive cycles

Taking Motherwort as the main line, it emphasizes that "the evidence is concentrated in post-abortion/post-cesarean section/postpartum hemorrhage, not ART scenarios" and highlights the "extrapolation of evidence" methodology and safety assessment, which is suitable for writing an in-depth review combining pharmacological and clinical evidence.[7]

Level of evidence for thermotherapy and ginger in menstrual symptom management: Implications for pre-assisted reproductive cycle comfort care

Focusing on the randomized controlled and systematic review evidence of "hot compress, hot water foot soak, and ginger" in primary dysmenorrhea, it is easier to form a structured "evidence table + recommendations" and clarify that its main function is to relieve pain/improve experience, rather than necessarily changing the biological endpoint of endometrial shedding.[8]

Differences in maternal vascular outcomes between artificial cycles and ovulatory cycle frozen-thaw embryo transfer and their impact on cycle selection: from corpus luteum loss to clinical decision-making

Incorporate into the discussion the "controllability" of HRT artificial cycles and the difference in risk of gestational hypertension/preeclampsia observed in some cohort studies, emphasizing the long-term outcome dimension of cycle selection; it can be expanded into an independent paper as a "background chapter".[9]

Standardization of endometrial baseline ultrasound interpretation based on menstrual dynamics: imaging indicators and quality control framework for the initiation of frozen-thaw embryo transfer cycles

It emphasizes the consistency of ultrasound interpretation, index standardization and quality control, and is suitable for producing methodological articles on "interpretation key points table, review thresholds, training and consistency assessment".[10]

════════ S1 Clinical Situation ════════
01
Section One · Clinical Context

Clinical Situation and Problem Definition

The key issue of "having menstruation the night before and preparing to start the HRT cycle the next day" is essentiallyBalance between two types of goals. One is the goal of cycle timing: the HRT cycle relies on exogenous estrogen to drive endometrial proliferation, and then exogenous progesterone triggers secretory phase transition. Finally, the "progesterone exposure days" are accurately aligned with the embryonic development age to obtain a suitable implantation window. The second is the baseline safety goal: before starting estrogen, it is necessary to confirm that the current bleeding is expected menstruation (or withdrawal bleeding) rather than abnormal bleeding, and to exclude obvious uterine lesions, persistent uterine effusion, recent pregnancy-related problems, or ovarian cysts and other conditions that may affect cycle execution.[11]

In real clinical practice, the doctor's logic of "carry out comfort/experience auxiliary treatment first, and then review the ultrasound the next day" usually includes: from the evening of the first day to the morning of the second day of menstruation, ultrasound may still show intrauterine blood/blood clots or uneven endometrium echo; short-term review can improve the understanding of "whether the shedding is completed and whether there is "Continuous effusion/suspected polyps or adhesions"; if the patient has dysmenorrhea, chills or obvious abdominal discomfort, heat therapy and drinking warm liquids can improve the experience; some traditional Chinese medicine (such as motherwort) is traditionally used to "activate blood circulation and regulate menstruation, promote the discharge of lochia/blood stasis", and will be empirically included in some institutions.[12]

But it needs to be clear: the international mainstream reproductive medicine guidelines usually lack direct entries on the specific operations of "failure/delay in starting the night before menstruation" and the recommendations on measures such as motherwort/brown sugar ginger water/foot soaking and hot compress to promote endometrial shedding. Therefore, this article adopts the "evidence-based evidence stratification" writing method: "Necessary medical decisions related to ART" and "auxiliary measures that may improve the experience" are separately described, and the limitations of evidence extrapolation are noted.[13]

════════ S2 Physiological Basics ════════
02
Section Two · Physiological Basis

The physiological basis of endometrium and menstruation

The endometrium is made ofbasal layerandFunctional layerconstitute. The proliferative phase of each cycle thickens under the dominance of estrogen; after ovulation, the corpus luteum secretes progesterone, causing the endometrium to enter the secretory phase and undergo decidualization-related changes in preparation for implantation; if there is no pregnancy, the degeneration of the corpus luteum causes the withdrawal of estrogen and progesterone, triggering the decomposition and bleeding of the functional layer of the endometrium, and then completes scar-free repair and regeneration on the basal layer.[14]

The key starting point for menstruation can be summarized as: "Progesterone withdrawal-initiation of local inflammation and tissue remodeling". Rhythmic contraction and reperfusion of uterine spiral arterioles are intertwined with hypoxic signaling, hemostasis, and repair processes. Physiology of Menstruation · Ref. 15

As for "whether the ultrasound on the next day can tell whether the endometrium has been shed completely", it is necessary to understand the time window of image performance from the dynamics of menstruation.early menstruation, varying degrees of fluid dark areas (blood) or echogenic masses (blood clots) can be seen in the uterine cavity; the endometrium line may be irregular, and uneven endometrium echo is common. As bleeding decreases and tissue is excreted, the endometrium gradually thins and becomes linear, and hematometra/fluid decreases.

It is worth emphasizing that in assisted reproduction, the relationship between endometrial thickness and pregnancy outcome is not monotonous and is not suitable for absoluteization. The expert consensus on "abnormal endometrium" issued by the Reproductive Medicine Branch of the Chinese Medical Association clearly states that,It is not recommended to evaluate receptivity, predict ART outcomes, or directly cancel transplant cycles based solely on endometrial thickness., but the thickness, morphological classification, hemodynamics, etc. should be comprehensively evaluated with patient and embryonic factors.[17]

════════ S3 HRT Cycle ════════
03
Section Three · HRT Cycle Overview

HRT Cycle Overview and Ultrasound Assessment Key Points

The advantages of HRT artificial cycles (also often called "programmed cycles, hormone replacement cycles") areStrong controllability: Through the sequential administration of exogenous estradiol and progesterone, the transition of endometrium from proliferation to secretion during the natural cycle is simulated, thereby arranging frozen-thaw embryo transfer with less reliance on ovulation monitoring. A systematic review pointed out that oral estradiol is often started on the 1st to 3rd day of menstruation in HRT cycles, and a fixed dose (such as 6 mg/day) or an ascending schedule can be used; the administration route can be oral, transdermal, vaginal, etc. The existing data generally suggest that the reproductive outcomes of different estrogen administration routes are similar.[18]

The start time and exposure days of progesterone are related to the HRT cycle"timeline core". In freeze-thaw transplantation, the clinical development age at the time of embryo freezing (such as D3 embryos, D5/D6 blastocysts) is often used to match the transplantation day after the onset of progesterone; there is still controversy about "the most appropriate length of progesterone exposure". Relevant reviews emphasize that the implantation window generally lasts 2-3 days, and the "duration of progesterone exposure" in the HRT cycle is one of the key variables that determines synchrony.[19]

HRT Cycle Timeline Core
D1 D2–3 D10–14 P+0 P+2~6 Exogenous estrogen · Intimal proliferation progesterone conversion Menstruation Day 1 The night before launch Baseline ultrasound estrogen kicks in Reassess endometrium form + blood flow progesterone onset Match embryo age embryo transfer D3 / D5 / D6

The clinical value of baseline ultrasound before starting an HRT cycle usually includes: confirming that there are no obvious abnormalities in the uterine cavity structure (such as obvious fluid accumulation, large polypoid echoes, suspicious adhesions), assessing whether the endometrium is close to the early menstrual baseline state, and checking whether there are functional cysts or dominant follicles in the ovaries. However, most reviews and consensus emphasize "comprehensive evaluation" rather than giving a uniform hard standard of "a certain millimeter threshold must be reached before starting estrogen."[20]

also,Cycle selection and long-term outcomesIt has also gradually entered clinical discussion: large cohort studies suggest that compared with ovulation cycle preparation (presence of the corpus luteum), artificial cycle freeze-thaw transplantation may have a higher risk of vascular complications such as preeclampsia during pregnancy. Researchers have proposed that the loss of luteal corpus-related factors may be one of the mechanisms. This does not deny the applicability of artificial cycles, but it suggests that ovulation cycles or modified natural cycles may have potential maternal benefits among people who are "able to ovulate and can be easily monitored."[21]

════════ S4 Interventions ════════
04
Section Four · Intervention Mechanisms

Theoretical basis and possible mechanisms of intervention measures

This section discusses the possible mechanisms according to the four types of measures recommended by doctors, and distinguishes "May affect pain/comfort"and"May affect bleeding/expulsion kinetics" at different levels. It needs to be stated in advance: the direct randomized evidence of these measures in menstrual management before ART initiation is very limited, and the mechanism inferences mostly come from dysmenorrhea studies, perinatal/post-abortion studies, pharmacology and extrapolation of traditional use experience.[22]

Leonuri HerbaA

Traditional descriptions of motherwort are often related to "activating blood circulation and regulating menstruation, diuresis and swelling, clearing away heat and detoxifying"; modern pharmaceutical research suggests that it contains many types of active ingredients, often discussed including stachydrine and motherwort/Leonurine, etc. Some studies have mentioned that it is related to the contraction of uterine smooth muscle, blood vessels and circulatory system.[23]

Judging from the clinical evidence that "may affect bleeding/discharge", the study related to motherwort that is closer to the goal of "promoting discharge/promoting recovery" isPerioperative or postpartum/postabortion scenario. Multicenter randomized controlled trials have shown that motherwort injection can reduce the amount and duration of vaginal bleeding after artificial abortion, and promote uterine involution. But this is not the same as the biological endpoint of "whether natural menstrual endometrium shedding is completed": menstrual shedding is dominated by tissue decomposition and repair triggered by the withdrawal of progesterone, while postoperative bleeding involves more uterine cavity wounds and uterine contraction and hemostasis, so extrapolation must be cautious.[24]

Furthermore, systematic reviews and randomized trials on the prevention of postpartum hemorrhage after cesarean section also show that motherwort injection combined with western uterotonic agents is associated with reducing bleeding volume and improving outcomes in some studies, but the review also emphasizes the issues of study quality and heterogeneity. In other words, the "strongest" part of the modern clinical evidence for Motherwort focuses on perinatal/postoperative hemostasis and uterine involution, rather than menstrual management before ART initiation.[25]

Ginger and brown sugar waterB

For ginger, there have been systematic reviews and meta-analyses in the field of primary dysmenorrhea:Pain Medicine Published systematic reviews summarizing randomized controlled trials consider use 3–4 days before menstruation or the first 3–4 days of menstruation 750–2000 mg ginger powder, may have a reducing effect on the pain scores of primary dysmenorrhea, but the overall evidence is still "suggestive" and the scale of the study is limited. Possible mechanisms generally revolve around anti-inflammatory effects and effects on the prostaglandin pathway.[26]

The core ingredients of brown sugar water are carbohydrates and trace minerals, which is strictly a dietary therapy/comfort care. For the specific proposition "brown sugar water can promote endometrium shedding", high-quality random evidence in the medical literature is publishedvery limited, more likely to be reflected in rehydration, providing heat, and improving warmth and comfort. If it is regarded as a "warm drink" rather than a "drug", it is more in line with the expression boundaries of the existing evidence.[27]

Thermotherapy · ThermotherapyC

Hot water foot soaking and hot compress on the lower abdomen can be included in the category of heat therapy. The evidence for hyperthermia in the management of dysmenorrhea is relatively clear:Scientific Reports A systematic review and meta-analysis including randomized trials showed that heat therapy is associated with a reduction in pain. Randomized controlled trials have also evaluated the value of heat patches (such as devices that provide a constant temperature source of approximately 40°C) versus analgesics, supporting the value of heat therapy in relieving menstrual pain.[28]

But similar to motherwort, the more certain clinical endpoint of hyperthermia is "Analgesia and quality of life improvement", rather than "accelerating the completion of endometrial shedding". From a pathophysiological point of view, menstrual pain is related to uterine contractions, prostaglandins, and local ischemia and hypoxia, and hyperthermia may alleviate these links; as for whether it can expel residual blood clots in the uterine cavity faster, there is a lack of direct imaging or mechanism research evidence.[29]

Positioning Clarification · Positioning

The reasonable positioning of the four types of measures in this scenario is"Comfort care and empirical assistance", rather than the core that determines the success or failure of the cycle. The core decision-making still relies on whether the baseline and follow-up ultrasounds can confirm that the uterine cavity and endometrium are in a startable state, and whether the subsequent estrogen and progesterone sequence is implemented as planned.

════════ S5 Guidelines Consensus ════════
05
Section Five · Guidelines & Consensus

Evidence and guideline consensus integration

From the perspective of evidence stratification, this clinical scenario involvestwo chains of evidence: The first is the reproductive medicine evidence chain of "FET endometrial preparation and HRT cycle specifications"; the second is the gynecological and complementary medicine evidence chain of "menstrual symptom management and uterine involution/hemostasis". The two evidence chains have obvious differences in research subjects, endpoint indicators, and intervention intensity. Therefore, it is necessary to clarify in writing "which ones can directly guide ART decisions, and which ones can only assist in explaining doctors' recommendations."[30]

Comparison of guidelines and consensus points
mechanism Recommendations for Intima Preparation with HRT/FET Baseline ultrasound/intimal shedding assessment Position on Motherwort, Ginger Water, and Heat Therapy Operational inspiration of this article
ESHRE[37] The official guide has extensive coverage, but not all topics have dedicated FET intima preparation guide entries. The evidence-based writing framework and ART process standardization guidance can be used for reference, but there are no direct provisions on the details of "recheck on the eve of menstruation and the next day". There is no direct recommendation for motherwort/brown sugar ginger water/foot hot compress in ART baseline management (marked "unclear/not covered"). Positioning such measures as "patient comfort care/empirical assistance", the core decision-making still relies on ultrasound and hormone timing.
ASRM[38] Public practice documents cover embryo transfer operating specifications; "programmed FET endometrium preparation starting point" relies heavily on reviews and central protocols. Emphasis is placed on procedures and quality control, and there are no special provisions for this scenario for "single indicator decision-making on intimal thickness". No direct recommendations are given for motherwort/ginger water/heat therapy in baseline management of ART. The "controllable, traceable, and evaluable" process concept: record the bleeding onset time, ultrasound baseline, review results, and medication time points.
Chinese Medical Association
Reproductive Medicine Branch[39]
Provides recommendations on diagnosis, treatment of abnormal endometrium and ART; the luteal support guideline provides options for alternative cycles. It is clearly stated that "it is not recommended to cancel cycles based solely on intimal thickness", need to consider thickness, shape, blood flow and embryo/patient factors. It does not appear as a standard recommended measure for abnormal endometrium in ART, indicating that it mostly falls within the scope of center experience and the practice of integrated traditional Chinese and Western medicine. Pay attention to "uterine effusion/residual echo/morphological abnormalities" instead of just focusing on millimeters; the progesterone support route can be selected according to the situation.
WHO[40] No direct clinical pathway guidance is provided for ART specific cycle regimens (HRT-FET baseline assessment). Emphasize the establishment of pharmacovigilance and supervision of traditional/complementary medicine products; adhere to the evidence-based principle and "no recommendation without evidence". All types of traditional/complementary medicine interventions are required to follow evidence-based standards in terms of safety and effectiveness, and no direct endorsement of individual herbal medicines in specific reproductive situations is required. Incorporate safety margins, contraindications, interactions and adverse reaction monitoring into the process before using herbal medicines or "empirical" measures.
Summary of key research evidence
theme Research/Review design and people intervention vs control main ending transformative
HRT cycle framework Mumusoglu et al. Systematic Review (1991–2021) Comparison of different preparation options Emphasis on individualization and evidence gaps Provides a "when to turn on estrogen" framework.[43]
Maternal Vascular Risks of Artificial Cycles Epelboin et al. National cohort (French database) AC-FET vs OC-FET vs fresh-ET AC-FET has high risk of preeclampsia (adjusted OR≈2.4) Cycle selection and long-term outcome decisions.[51]
Evidence for hyperthermia analgesia Jo & Lee Systematic reviews and meta-analyses (RCTs) Heat source vs placebo/drug Heat therapy linked to pain reduction Supports "hot compress to relieve menstrual cramps" comfort care.[52]
Thermostatic patch vs medicine Navvabi Rigi et al. randomized controlled trial 40°C hot patch vs ibuprofen Pain trends in the previous 24 hours were similar "Hot compress on the lower abdomen" is a safe and effective way to manage dysmenorrhea.[53]
Ginger dysmenorrhea evidence Daily et al. Systematic reviews and meta-analyses (RCTs) Ginger powder vs placebo/medication 750–2000 mg/day reduces pain scores Ginger can be used as a menstrual cramps symptom relief option.[54]
Ginger dosage and safety EMA Herbal Monograph EU herbal monograph 0.25–1g, 3 times daily In principle, avoid during pregnancy; adverse gastric reactions Define "acceptable dosage and adverse effects".[56]
Motherwort·Postoperative bleeding Xia et al. Multicenter RCT (after abortion) Motherwort injection vs no treatment Reduce the amount and duration of bleeding Evidence of uterine involution/hemorrhagic kinetics.[57]
Motherwort·Caesarean section bleeding Chen et al (systematic review) Systematic review (48 RCTs) Motherwort injection + Western medicine vs Western medicine Reduce intraoperative and postoperative bleeding Macroscopic evidence of hemostasis; indirectly related to ART dropout.[58]
Motherwort·Medicinal Materials Standard Chongqing Local Preparation Standards / Malaysian T&CM Formulary Official Formulary/Local Standards Dosage 9–30 g; contraindicated during pregnancy Standardized Dosage and Warnings "Dose, contraindications, quality control" boundaries.[59][60]
════════ S6 Safety and Recommended Process ════════
06
Section Six · Safety & Protocol

Safety, contraindications, recommended procedures and education

Safety and contraindicationsSafety

Motherwort
Leonuri Herba · Taboo

Risks during pregnancy: Both local medicinal material standards and traditional medicine formularies include pregnancy as aContraindications or situations of caution. In the context of ART, even if the patient has already had menstruation, it is still recommended to take any "potential bleeding/promoting uterine" medication before taking it.Confirm that there is no possibility of pregnancy(Test beta-hCG if necessary), be extra cautious for those with menorrhagia, abnormal coagulation, or those taking anticoagulant/antiplatelet medications.[61]

ginger
Zingiber · Safe in normal dietary amounts

The overall safety is good when used in normal diet or traditional dosage, but it is preferred to avoid it out of prudence during pregnancy; common adverse reactions include stomach discomfort, belching, heartburn and nausea.Those with gastroesophageal reflux, gastritis or sensitivity to spicy foodThe dose should be kept low, taken after meals, and stopped when heartburn worsens.[62]

Hyperthermia
Thermotherapy · Temperature control

The main risk comes from "temperature and time out of control"low temperature burns, especially those with reduced skin sensation (such as diabetic peripheral neuropathy) or those who use it while sleeping. It can be used at a constant temperature of about 40°C. In clinical practice, direct contact with the skin and prolonged high fever should be avoided. You should also pay attention to the risk of orthostatic hypotension when soaking your feet.[63]

Actionable recommendation processProtocol

The following plan starts with "Lowest risk, within evidence-based boundaries"In principle, a clear distinction is made between "key actions that must be decided by the reproductive center" and "comfortable care that the patient can perform at home." The specific dosage and starting and ending time points must be subject to the requirements of the prescribing doctor.[64]

T−1The night before launch
▲ Led by clinical team

Record the onset time, amount, and abdominal pain of bleeding. Pregnancy is excluded if necessary (urine or blood β-hCG).

● Patient can perform

Rest, soak your feet in warm water (38–42°C), and apply “warm but not hot” heat to the lower abdomen for 15–30 minutes. If dysmenorrhea is obvious, you can use general analgesics as directed by your doctor.

T0Menstrual Day 2–3
▲ Transvaginal ultrasound baseline assessment

Record the thickness of the endometrium, whether the endometrium line is regular, uterine effusion/hematopse, focal echo (polypoid, adhesion-like), and ovarian cyst/dominant follicle.[65]

● Comfort care

Apply hot compress 1-3 times a day; consume ginger at a low dose for dietary therapy, and stop if you have stomach discomfort. Avoid combining with other supplements that may affect blood clotting.[66]

T+24hCheck again after 24 hours
▲Re-examination ultrasound (if affected by blood clot for the first time)

Observe whether the uterine cavity contents and endometrial morphology are significantly improved. Patients with persistent uterine effusion require individualized treatment, and transplantation can be canceled/postponed if necessary.

● Motherwort (if prescribed by doctor)

Positioned as "empirical assisted discharge/menstrual regulation". Common dosage for oral administration is 9–30 g (based on tablets/medicinal materials),Rule out pregnancy firstand monitor bleeding changes.[61]

T+10~14dpost estrogen
▲Re-evaluate intimal thickness/morphology

Determine whether the center's "entering progesterone" conditions are met; if the standard is met, progesterone conversion will begin, the number of exposure days will be matched according to the age of the embryo, and the transplant will be arranged.

● Warning Signs

Change sanitary napkins every hour, dizziness, fatigue, syncope, persistent fever, foul-smelling secretions, severe abdominal pain → seek medical attention immediately

Ultrasound interpretation dimension of "sufficient shedding"Readout

Since the activation thresholds of different centers are not unified, this article gives"Interpretation dimension"Rather than a single millimeter line.[67]

01
intimal line

Is it clear and linear?

02
uterine cavity contents

Is there still obvious blood/fluid accumulation?

03
echo uniformity

Is the intimal echo significantly uneven?

04
focal cues

Strong echo/vegetation/adhesion

05
consistency of symptoms

Is the amount of bleeding consistent with the image?

clinical decision algorithmAlgorithm

Decision-making process before starting an HRT cycle
A. Menstrual bleeding the night before Patient plans to initiate HRT cycle B · Information confirmation Bleeding onset/amount/abdominal pain; beta-hCG to rule out pregnancy if necessary C· Transvaginal ultrasound baseline assessment Menstruation Day 2–3 D · Interpretation of uterine cavity and endometrium Three types of branches Clear intima · No effusion E·Initiate estradiol according to protocol Record start date and dose →Reassess after 10–14 days Hematometra/more blood clots F·Observation + Comfort Care Hyperthermia · Symptom Control → 24 h review ultrasound Persistent effusion / clues to pathology G · Pause/Delay Cycle further evaluation Hysteroscopy if necessary H · Review improvement? whether Significant improvement → E Not improved → G

Patient education pointsPatient Education

What patients need to understand most in this situation is "Which phenomena are normal menstrual fluctuations and which ones require timely contact with a doctor?". Within the normal range, abdominal pain, backache, blood clots, temporary chills and mood swings may occur 48 hours before menstruation; however, if sanitary napkins need to be changed every hour, dizziness and weakness, syncope, persistent fever, foul-smelling secretions, severe abdominal pain or unilateral progressive pain occur, you should seek medical attention as soon as possible to rule out infection, ectopic pregnancy or other emergencies.[68]

critical communication framework

Regarding "Whether motherwort, ginger water, and hot compress must be done", it is recommended to regard them as "Optional auxiliary tools", rather than the core that determines the success or failure of the cycle. The key node that really determines whether the HRT cycle can be advanced is whether the baseline and reexamination ultrasound can confirm that the uterine cavity and endometrium are in a start-up state, and whether the subsequent estrogen and progesterone sequence is implemented according to the plan. If the patient has concerns about herbal medicine, he can discuss with the doctor only the use of heat therapy and general analgesic strategies; if the doctor insists on recommending herbal medicine, the purpose, dosage, treatment course and withdrawal trigger points should be clearly defined, and all drugs and health products being used should be informed simultaneously.[69]

════════ S7 Research Gaps ════════
07
Section Seven · Research Gaps

Research Gaps and Future Research Suggestions

The biggest gap in the existing evidence for this scenario is the lack of "Completeness of endometrial shedding before ART cycle initiation" is a prospective study with the primary endpoint. Dysmenorrhea studies often use VAS pain as the primary endpoint; Motherwort studies mostly focus on postpartum/postabortion bleeding and uterine involution; while HRT cycle studies focus more on pregnancy outcomes, progesterone exposure time and protocol comparison. To write the process of "menstruation the night before - ultrasound the next day - reexamination the next day" into a real evidence-based guideline, at leastThree types of new research[70]

01
imaging endpoint studies

Standardized transvaginal ultrasound interpretation (endometrial line clarity, uterine effusion quantification, echo uniformity, and three-dimensional/blood flow parameters when necessary) was used as the primary endpoint to compare the image improvement rate within 24–48 hours of strategies such as "observation reexamination only" and "observation + hyperthermia/ginger/motherwort", and record whether it affects subsequent estrogen initiation time and cycle cancellation rate.[71]

02
Patient experience-centered outcomes

The short-term goal does not have to be set to "faster endometrium shedding", but can be set to relieve dysmenorrhea, reduce anxiety, increase the sense of control over the cycle, and improve compliance with follow-up visits. Heat therapy and ginger can be entered into randomized trials as candidate interventions; brown sugar water can be used as a control or common background care.[72]

03
Safety and interaction studies

Especially for "potential hemorrhage/promoting uterine contraction" interventions such as Motherwort, it is necessary to record excessive bleeding, allergic reactions, changes in coagulation indicators and the impact on subsequent endometrial reactions in the ART population. The combination of real-world cohorts and pharmacovigilance systems can be considered.[73]

04
Methodology: Ultrasound Interpretation Consistency

Carry out interpretation standardization, training and consistency assessment for multiple centers, establish a repeatable imaging quality control framework, and provide a unified basis for "reexamination thresholds".

Clinical Takeaway

If you are preparing for a FET/HRT cycle, what is the most worthwhile thing to take away from this article?

What this article really wants to solve is not to package every empirical practice into a standard answer that "must be performed", but to help patients and doctors establish a communicable, reviewable, and adjustable judgment framework within 24 hours before the start of the cycle. If you would like to discuss further based on your own report, hormone regimen or transplantation rhythm, we can break down the key points of the next step of preparation according to your specific situation.

References · Cited documents

A total of 73 in-text citations, combined into 21 independent sources. Click to view the original text.
  1. 01Frontiers in Endocrinology · fendo.2021.688237
    [1][3][11][18][30][31][43][70]
  2. 02Human Reproduction Update · 21(6):748
    [2][36]
  3. 03ScienceDirect · S1550830719304471
    [4][7][12][24][35][40][57]
  4. 04Scientific Reports · s41598-018-34303-z
    [5][8][28][29][52][72]
  5. 05Chinese Medical Association consensus on abnormal endometrium
    [6][10][17][20][33][46][47][64][65][69][71]
  6. 06Frontiers in Endocrinology · 2023.1182148
    [9][21][51]
  7. 07ESHRE · Guidelines & Legal
    [13][37][41][42][55]
  8. 08JCI Insight · view/163422
    [14]
  9. 09ScienceDirect · S1043276098000782
    [15]
  10. 10Chinese Medical Association·Luteal Support Guidelines
    [16][67]
  11. 11ScienceDirect · S0015028222005313
    [19]
  12. 12WHO · WHA78 Annex
    [22][27][50]
  13. 13Die Pharmazie · 67(12):S973
    [23]
  14. 14Chen Systematic Review·Caesarean Section Hemorrhage
    [25][58]
  15. 15Pain Medicine · 16(12):2243
    [26][34][54]
  16. 16Journal of Reproductive Medicine·Endometrial Preparation Review
    [32][39]
  17. 17BMC Women's Health · 12-25
    [38][53][63][66]
  18. 18ASRM · Embryo Transfer Guideline 2017
    [44][45]
  19. 19WHO · Traditional Medicine Q&A
    [48][49][73]
  20. 20EMA · Zingiber Officinale Monograph
    [56][62]
  21. 21Chongqing · Motherwort Processing Specifications
    [59][61]
中文ENRU